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Introduction
Ask a class of schoolchildren “Who discovered penicillin?” and 
the spontaneous response will invariably be “Alexander Fleming!” 
(I should add that this is not a contrived dramatic entrée to 
what follows; I have actually posed this question on a number 
of occasions to schoolchildren and it has never failed to elicit 
this response). However, there are those who claim that what 
children have been taught – and indeed are still being taught – 
about penicillin is incorrect, and that it was in fact discovered long 
before Fleming noticed the lytic action of a contaminating mould 
belonging to the genus Penicillium on staphylococci sometime in 
the late summer of 1928.
These avant la lettre claims are not centred on one individual; 
there are in fact a clutch of scientists that have been credited 
as being the “true” discoverers of penicillin by their various 
advocates. The earliest challenge to Fleming’s status as discoverer 
that I have come across appeared in an article published in 1944 
[1] at the height of media interest in the mass production of 
penicillin. The author, Jules Brunel a botanist, appears at first 
to propose André Gratia and Sara Dath as the true discoverers 
for work they conducted in 1925, and which he claimed bore 
a “striking parallelism” to the work of Fleming, but later in his 
paper appears to credit Adriano Sturli for observations that he 
published in 1908. Numerous other supposed precursors to 
Fleming also receive mention in what comes across as a polemic, 
punctuated with a number of exclamation marks, and published 
to set the record straight. Appearing shortly after Brunel’s claim is 
that of Maddren [2] who credits the polymath John Tyndall with 
having made an “early observation of penicillin” in 1875. Starting 
in 1949 a number of claims have accrued around the French 
military doctor Ernest Duchesne who published his doctoral 
thesis in 1897 [3]. Some of these claims appear to be tainted 
by chauvinistic motives but this is nowhere more obviously the 
case than in assertions emanating from the former Soviet Union 
during the Cold War. In an essay on Russian scientific claims 
published in 1950 [4], Boltz stated that “aggressive nationalism 
and scientific truths make strange bedfellows” and he then 
went on to refute claims that Russian scientists had discovered 
penicillin eighty years prior to the publication of his essay, 
and also that they had invented the radio and the aeroplane. 
In 1953 The Guardian newspaper reported that the Russian 
Academy of Medical Science had decided to publish the works 
of Alexei Gerasimovitch Polotebnov in order to prove that he 
had discovered penicillin in 1872 [5]. More recently, Dumont [6] 
champions the case of the New York surgeon Frederick S. Dennis 
based on an article that Dennis had published in 1885. Whilst in 
his widely acclaimed book, Bad Medicine, David Wootton seeks 
to credit both Joseph Lister – for observations made in late 1871/
early 1872 - and Ernest Duchesne who he claims, independently 
discovered penicillin and took it “somewhat further than Fleming 
did” [7]. In an earlier paper, Zuck [8] had argued that Lister had 
been motivated in his investigations by the work of Burdon 
Sanderson conducted in 1871.
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In what follows I want to evaluate such claims based on the 
current status of Penicillium systematics along with findings 
relating to the metabolites produced by species belonging to this 
genus – essentially the same approach which I used to refute the 
claims made specifically relating to Ernest Duchesne [9].
What Alexander Fleming observed on that now famous petri 
dish in 1928 constitutes an example of microbial antagonism. 
He was certainly not the first to observe this phenomenon. In 
fact, even attributing the discovery of microbial antagonism to 
a single individual is not possible. I contend that it comes under 
the category of a “simultaneous discovery” a term which the 
philosopher of science, Thomas Kuhn, most famously applied 
to the emergence of the principle of the conservation of energy 
[10]. Simultaneous discovery may be defined as a number of 
scientists working independently of one another and announcing 
identical, or similar, discoveries within a few years of each other. 
Since Kuhn’s pioneering work there have been a number of other 
examples of simultaneous discoveries put forward including 
the periodic table [11]. Kuhn himself baulked at the prospect 
of identifying all those involved in formulating the principle of 
energy conservation, and similarly it is not my intention here to 
list all those pioneers of microbial antagonism, as attempting to 
do so would exceed my limited knowledge of foreign languages. 
Notwithstanding, the phenomenon began to be investigated in 
the 1870s. A subset of those involved includes Thomas Huxley 
(1870) Robert Burdon Sanderson (1871), William Roberts (1874) 
and John Tyndall (1875). What factor(s) might have motivated 
them? Whilst it is no simple matter to attempt to recreate the 
zeitgeist under which these men conducted their investigations, 
it is surely significant that they all postdate the publication in 
1859 of On the Origin of Species by Means of Natural Selection by 
Charles Darwin. What was under investigation was nothing less 
than the “the struggle for life,” but applied to micro-organisms 
rather than to members of the Animal Kingdom. One can even 
discern oblique references to Darwin in work published in 1877 
by Pasteur and Joubert on bacterial antagonism of the anthrax 
bacillus: “among inferior organisms [i.e. micro-organisms] more 
so than in the higher animals and plants life prevents life [la 
vie empêche la vie]” [12]. The first French edition of Darwin’s 
momentous work appeared in 1862 [9] and Darwin’s phrase 
“struggle for life” came to be translated as “concurrence vitale,” 
and the term soon gained wide circulation. It appears in the title 
of Ernest Duchesne’s thesis mentioned above.
In the 1870s fungal systematics was at a very rudimentary phase. 
Arthur Henrici, a mycologist, writing in 1930 complained of the 
tendency in the earlier literature, and even at the time of writing, 
to assign all “green forms” to the species Penicillium glaucum, 
and that this designation had been used so indiscriminately that 
it had become worthless [13]. Later, Raper & Thom [14] pointed 
out that these assignments were being made in the absence of 
an adequate description of the species. According to the most 
recent taxonomic assessments there are 354 species within the 
genus Penicillium only 8 of which produce penicillin [15]
Turning now to the nature of metabolites produced by members 
of this genus; penicillin itself is of course a secondary metabolite. 
These are compounds which confer advantages to the organism 
producing them but which are not indispensable to them as 
are primary metabolites. A recent estimate puts the number 
of secondary metabolites elaborated by the genus Penicillium 
as 1338 [16]. A good proportion of these display antibacterial 
properties, but included amongst them are compounds that are 
toxic and referred to as “mycotoxins” and could simply not serve 
as antibiotics.
The fact that Fleming was not the first to observe microbial 
antagonism does not in any way constitute evidence that any of 
the studies referred to above, even if they were conducted with 
species of Penicillium, involved that specific chemical entity which 
we refer to as “penicillin.” Indeed, the statistics presented above 
concerning the number of species of Penicillium now known 
to exist along with the vast number of secondary metabolites 
they elaborate would render the possibility that a particular 
environmental isolate belonging to the genus Penicillium, and 
routinely classified as Penicillium glaucum, actually produced 
penicillin as vanishingly small. In the interests of balance it should 
be added that not all historical reviews of early observations of 
microbial antagonism involving penicillia contain claims regarding 
penicillin which cannot be substantiated. With reference to the 
Austrian surgeon Theodor Billroth, Majno and Joris [17] show 
that between 1868 and 1873 he worked with cultures of bacteria 
and moulds and conclude that he “may have been the first to 
observe an inhibitory effect of Penicillium on bacteria” they then 
go on to qualify this statement by adding “we cannot be sure 
that the strain of Penicillium that he observed truly produced 
penicillin” - an infinitely more sober and realistic assessment than 
any of those cited above.
In his book Fabulous Science [18], the author, John Waller, 
defines his objective as seeking to separate fact from fiction 
in accepted accounts of scientific discoveries. In a chapter on 
penicillin entitled “Fleming’s Dirty Dishes,” Waller has recourse 
to that celebrated quotation of Shakespeare’s concerning the 
ways by which a person attains greatness; viz. “some are born 
great, some achieve greatness, and some have greatness thrust 
upon them,” but finds it necessary to create another category 
to cover the case of Alexander Fleming, i.e. those who, “having 
let greatness slip through their fingers, snatch it back from those 
who have a better claim” (!). Difficulties arise when attempting 
to credit a single individual with a discovery as this distorts the 
way in which discoveries actually take place. Discoveries tend 
to be processes rather than isolated single events. Perhaps the 
first realistic assessment to appear in print of the stages by which 
penicillin came to be bestowed upon humanity is provided in a 
letter written by Professor Robert Robinson of Oxford University 
to The Times of London in September, 1942 [19]. An item on 
penicillin had appeared a few days earlier, and Robinson, whilst 
acknowledging that Fleming had indeed discovered penicillin, 
pointed out that it was Howard Florey and his co-workers who 
had “separated therapeutic penicillin” and demonstrated its 
clinical value.
To return to Alexander Fleming; he witnessed an example of 
microbial antagonism - in Kuhn’s term the “that” [20]. He formed 
an idea that the mould was producing “a simple substance” 
[21] that was diffusing through the agar and causing the lysis of 
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growing colonies of Staphylococcus aureus  the “what” as Kuhn 
referred to it. He took steps to preserve his culture, and asked 
a mycologist to identify it for him. Fleming tried, but failed, to 
extract the penicillin from the mould broth. Moreover, he made 
the mould freely available to those that asked him for it. In a 
letter written during the war he stated that he had sent out “a 
very large number of cultures” [22]. When Florey and his group 
decided to begin their investigation of microbial antagonism 
a decade later with penicillin at the Sir William Dunn School of 
Pathology in Oxford, they were able to acquire a culture from a 
colleague, Margaret Campbell-Renton, at the Dunn School who 
had been culturing the strain for her own work on bacteriophages. 
The strain had been sent to Oxford by Fleming himself. It was 
Fleming’s strain which Florey and his co-worker Norman Heatley 
took to the USDA laboratories in Peoria, Illinois and from which 
the first batches of penicillin for therapeutic use were made. 
No cultures of the penicillia used by the earliest investigators of 
microbial antagonism have come down to us, and it is therefore 
not possible to establish whether any of them actually produced 
penicillin. My argument is founded on the low probability that 
penicillin was involved, but by the same token, it cannot be 
proven with absolute certainty.
It is pertinent to enquire when the process of discovery might 
have been initiated. However, it turns out not to be possible to 
assign a specific date. Until very recently the earliest evidence 
for the use of moulds for therapeutic purposes was thought to 
be contained in the so-called “Ebers Papyrus” which dates back 
to circa 1500 BC and wherein mention is made of the application 
of “rotted cereals” for the treatment of diseases of the skin [23]. 
However, newly published work [24] on the analysis of the dental 
calculus of a 48, 000 year old specimen of Homo neanderthalensis 
from Spain has revealed the presence of the DNA of Penicillium in 
this individual who suffered from a severe dental abscess inviting 
speculation that substrates on which mould was growing might 
have been deliberately consumed for their medicinal properties. 
Whether the origin of using moulds therapeutically dates back to 
our hominin relatives or to pharaonic times cannot be determined 
with certitude. However, one thing is certain, and that is that the 
practice was passed down through time: there are numerous 
references in the literature to folk medicines comprising mouldy 
starch-containing substrates – typically bread – being applied to 
cure skin infections. The fact that such practices became both 
culturally widespread and persisted over time would suggest that 
they were efficacious to some extent, or in certain circumstances. 
An interesting series of letters appeared in The Sunday Times 
newspaper under the heading of “Gypsies’’Penicillin’” in 1958 in 
which various folk remedies were described [25]. These included 
the application of the following mouldy substrates; wheat straw, 
cheese and leather to the infected part. It is relevant to draw 
attention here to the findings of Wainwright [26] who documents 
an example from as late as 1929 (the year in which Fleming’s paper 
on penicillin appeared) in which a young girl suffering from the 
skin infection, impetigo, was successfully cured of her condition 
by the application - on the recommendation of a physician - of 
a starch paste that had been allowed to become mouldy to the 
affected region. Alexander Fleming may or may not have had 
knowledge of such practices. Notwithstanding, it seems highly 
probable that Fleming had an awareness of the phenomenon of 
microbial antagonism: Leonard Colebrook, a close associate of 
his at St Mary’s Hospital, had published an article on bacterial 
antagonism involving Meningococcus in 1915 [27].
Whilst I disagree with Waller’s comments (quoted above) as to 
how Alexander Fleming achieved greatness, I would like to take 
this opportunity to “re-mould” some of the terms he uses rather 
as a potter might re-model a clay pot that showed no signs of 
its ultimately being able to hold water… What Fleming did when 
he noticed that most common of occurrences - a contaminated 
petri dish - was not to let it "slip through his fingers"; rather the 
knowledge he had accrued over the years both in his work and 
by “playing with microbes” led him to "snatch it back" from the 
tray of Lysol in which it had been standing, as a result of which 
he earned that portion of greatness which was rightly his due for 
the part he played in the process by which that highly effective 
chemotherapeutic agent – penicillin - came to be bequeathed to 
humanity.
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